Showing results (201-210 of 253) with videos related to

Sort By:
Pageof 26
Transplantation|November 19, 2016
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo OsseoMichele Malagola, Valeria Cancelli, Cristina Skert, et al.
Blood|August 13, 2011
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomideAlessandra Larocca, Federica Cavallo, Sara Bringhen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL StudyPaolo Corradini, Chiara Agrati, Giovanni Apolone, et al.
Blood Advances|February 7, 2019
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCLPeter Dreger, Anna Sureda, Kwang Woo Ahn, et al.
Blood Advances|April 6, 2019
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Tamara Intermesoli, Arianna Masciulli, et al.
Nature Communications|April 23, 2020
Timing the initiation of multiple myelomaEven H Rustad, Venkata Yellapantula, Daniel Leongamornlert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple MyelomaLuca Bertamini, Stefania Oliva, Delia Rota-Scalabrini, et al.
Leukemia|May 24, 2018
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroupsNiccolo Bolli, Giulia Biancon, Matahi Moarii, et al.
Journal of Cancer Research and Clinical Oncology|April 21, 2018
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysisChiara Cerrato, Francesco Di Raimondo, Lorenzo De Paoli, et al.
Blood Cancer Discovery|July 2, 2024
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell LymphomasFederico Stella, Annalisa Chiappella, Beatrice Casadei, et al.
Pageof 26